Protagonist Therapeutics PTGX
NASDAQ PTGX
$140.06 +0.87 (+0.63%)
At close: Oct 2, 2026 · 4:00 PM EDT

Protagonist Therapeutics (PTGX) Price to Earnings (2024 - 2026)

Updated

Protagonist Therapeutics' (PTGX) Price to Earnings was 95.62 for Q2 2026, up 45.0% from 65.96 a year earlier.

Analysis

Protagonist Therapeutics (PTGX) Price to Earnings (2024 - 2026) Analysis & Trends

For FY2024, Price to Earnings at Protagonist Therapeutics was 8.56.

  • The Q2 2026 figure ranks as the highest quarterly Price to Earnings in data going back to Q1 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Protagonist Therapeutics 9.06 Bn 9.06 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 95.62
Sep 30, 2025 90.36
Jun 30, 2025 65.96
Mar 31, 2025 53.30
Dec 31, 2024 8.56
Sep 30, 2024 15.68
Jun 30, 2024 11.98
Mar 31, 2024 10.46
API Access

Protagonist Therapeutics Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=PTGX&period=max&api_key=YOUR_API_KEY